ALT-711: Began Phase IIa trial

Alteon Inc. (ALTN), Ramsey, N.J. Product: ALT-711 Business: Metabolic Therapeutic category: Metabolism Target: A.G.E.s Description: Advanced Glycosylation End-product (A.G.E.) crosslink breaker Indic...